Medical Device Developments Weekly: 27/09/23
Medical Device Developments
Latest news and insight on innovations in the Medical Device sector.
The latest insight and analysis from the global medical device market from the last week courtesy of Medical Device Developments
Motif Neurotech completes FIH study of brain stimulator implant for treatment-resistant depression
US-based Motif Neurotech has designed the miniature brain pacemaker to precisely stimulate the brain to restore healthy circuit functioning to treat mental health disorders.
The study, published in the preprint server medrxiv, was conducted by the neurotechnology firm in partnership with researchers at Rice University, Baylor College of Medicine, and UTHealth Houston.
The millimetre-sized brain stimulator is indicated for treatment-resistant depression (TRD), a subtype of major depressive disorder (MDD). It is enabled by wireless magnetoelectric power transfer technology.
Read more: bit.ly/45TyLx1
Medtronic secures CE mark for new Simplera CGM device
Medtronic has designed the all-in-one, disposable Simplera with a simple, two-step insertion process and improved user experience.
The latest no-fingerstick sensor, which does not need over tape, works in tandem with the InPen smart insulin pen, which offers real-time, individualised dosing assistance to help make managing diabetes easier.
Read more: bit.ly/3PNTT1W
INBRAIN Neuroelectronics gets FDA breakthrough nod for Intelligent Network Modulation System
The FDA’s BDD covers the graphene-neural platform as an adjunctive therapy for the treatment of Parkinson’s disease.
The INBRAIN Neuroelectronics system uses the two-dimensional substance graphene, which is formed of a lattice of carbon atoms that is only one atom thick.
INBRAIN Neuroelectronics’s neural platform technology combines machine learning software that decodes therapy-specific biomarkers and ultra-high signal resolution.
Read more: bit.ly/46myIcz
Exactech gets FDA 510(k) clearance for Activit-E polyethylene system
Recommended by LinkedIn
Activit-E is a highly crosslinked polyethylene of the most recent generation stabilised with vitamin E antioxidants.
The polyethylene system is said the latest addition to Exactech’s Vantage ankle portfolio.
The FDA clearance follows the Activit-E clearance for the Truliant Knee System, which was announced last month.
Read more: bit.ly/3ZsrG3W
Biomerics completes expansion of Brooklyn Park facility in US
The expansion, driven by increased demand, will benefit the customers and consolidate the medical device company’s multiple facilities under one roof.
It will also expand the company’s engineering centres of excellence for complex extrusions, laser processing, advanced catheters and steerables, and final assembly operations.
Biomerics’ main facility at Brooklyn Park facilitates the design, development and production of complex and specialised catheters, steerable devices and delivery systems.
Read more: bit.ly/48puvH9
Upcoming webinars
Recommended webinars
- 1Factory: Automated Quality Control for Medical Device Manufacturing
- Loftware Siemens: The challenge of labeling & UDI for medical devices
Thanks for reading; we hope you enjoyed it.
Until next week.
To have a story featured on next week's newsletter - contract Medical Device Developments or Martin John directly.
Product Manager (YaNing One-Stop Clear Solution )
1y-Precision Parts supplier